Brief: Consun Pharmaceutical Group posts HY profit attributable RMB184.8 million
Aug 24 (Reuters) - Consun Pharmaceutical Group Ltd 1681.HK
* Board declared payment of an interim dividend of HKD0.096
per share for six months ended 30 june 2017.
* HY profit attributable RMB184.8 million an increase of
27.1%
* Board has declared payment of an interim dividend of
HKD0.096 per share
* Revenue for HY amounted to RMB769.4 million, up 70.3%
Source text for Eikon: urn:newsml:reuters.com:*:nHKS6Z3byz
Further company coverage: 1681.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Consun Pharmaceutical
See all newsChina's Consun Pharmaceutical H1 revenue rises on sales network expansion
Brief: Consun Pharmaceutical Says Unit To Invest RMB191.4 Mln In Shanghai Huamao Pharmaceutical
Brief: Consun Pharmaceutical Group Announces Share Repurchase Program Up To HKD200 Million
Brief: Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln
Brief: Consun Pharmaceutical Says Executive Director Zhu Quan Redesignated As Non-Executive Director